KRTX stock is having its biggest one-day gain and has hit a new high after Karuna Therapeutics Inc (NASDAQ:KRTX) announced positive results from a Phase 2 clinical trial evaluating KarXT in schizophrenic patients with acute psychoses.
Investors Cheer the NewsWhenever a pharmaceutical or therapeutics firm announces positive news with regards to any of its products in the pipeline, there is almost always a positive effect on the stock. That is what happened with KRTX stock this morning after Karuna Therapeutics revealed highly encouraging results from the Phase 2 clinical study of its product KarXT. The ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.